169 related articles for article (PubMed ID: 31569112)
21. Bleomycin Polidocanol Foam (BPF) Stability - In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations.
Sun Y; Gu H; Yang X; Cai R; Shang Y; Hu L; Wang Y; Chen H; Lin X
Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):1011-1018. PubMed ID: 32063463
[TBL] [Abstract][Full Text] [Related]
22. Foam sclerotherapy: an overview of use for primary venous insufficiency.
Guex JJ
Semin Vasc Surg; 2005 Mar; 18(1):25-9. PubMed ID: 15791550
[TBL] [Abstract][Full Text] [Related]
23. Physiochemical properties and reproducibility of air-based sodium tetradecyl sulphate foam using the Tessari method.
Watkins MR; Oliver RJ
Phlebology; 2017 Jul; 32(6):390-396. PubMed ID: 27329670
[TBL] [Abstract][Full Text] [Related]
24. Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe?
Goldman MP
Dermatol Surg; 2004 Dec; 30(12 Pt 1):1454-6; discussion 1456. PubMed ID: 15606731
[TBL] [Abstract][Full Text] [Related]
25. Foam sclerotherapy.
Alder G; Lees T
Phlebology; 2015 Nov; 30(2 Suppl):18-23. PubMed ID: 26556698
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Bush R; Bush P
Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
[TBL] [Abstract][Full Text] [Related]
27. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm.
Barrett JM; Allen B; Ockelford A; Goldman MP
Dermatol Surg; 2004 Nov; 30(11):1386-90. PubMed ID: 15522019
[TBL] [Abstract][Full Text] [Related]
28. An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
Peterson JD; Goldman MP
Dermatol Surg; 2011 Jan; 37(1):12-7. PubMed ID: 21199095
[TBL] [Abstract][Full Text] [Related]
29. Venous disorders: treatment with sclerosant foam.
Bergan J; Pascarella L; Mekenas L
J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
[TBL] [Abstract][Full Text] [Related]
30. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
Willenberg T; Smith PC; Shepherd A; Davies AH
Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
[TBL] [Abstract][Full Text] [Related]
31. Studies on Foam Decay Trend and Influence of Temperature Jump on Foam Stability in Sclerotherapy.
Bai T; Chen Y; Jiang W; Yan F; Fan Y
Vasc Endovascular Surg; 2018 Feb; 52(2):98-106. PubMed ID: 29173136
[TBL] [Abstract][Full Text] [Related]
32. Influence of Syringe Volume on Foam Stability in Sclerotherapy for Varicose Vein Treatment.
Bai T; Jiang W; Fan Y
Dermatol Surg; 2018 May; 44(5):689-696. PubMed ID: 29140865
[TBL] [Abstract][Full Text] [Related]
33. Complications and side-effects of foam sclerotherapy.
Guex JJ
Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
[TBL] [Abstract][Full Text] [Related]
34. Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model.
McAree B; Ikponmwosa A; Brockbank K; Abbott C; Homer-Vanniasinkam S; Gough MJ
Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):721-5. PubMed ID: 22507925
[TBL] [Abstract][Full Text] [Related]
35. Sclerotherapy and foam sclerotherapy for varicose veins.
Coleridge Smith P
Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
[TBL] [Abstract][Full Text] [Related]
36. Properties of polidocanol foam in view of its use in sclerotherapy.
Nastasa V; Samaras K; Ampatzidis Ch; Karapantsios TD; Trelles MA; Moreno-Moraga J; Smarandache A; Pascu ML
Int J Pharm; 2015 Jan; 478(2):588-96. PubMed ID: 25433198
[TBL] [Abstract][Full Text] [Related]
37. Foam sclerosants are more stable at lower temperatures.
Valenzuela GC; Wong K; Connor DE; Behnia M; Parsi K
Eur J Vasc Endovasc Surg; 2013 Nov; 46(5):593-9. PubMed ID: 24070851
[TBL] [Abstract][Full Text] [Related]
38. [Phlebosclerosing treatment of lower extremity varicosity using the 'foam-form' technique].
Bogachev VIu; Zolotukhin IA; Briushkov AIu; Zhuravleva OV
Angiol Sosud Khir; 2003; 9(2):81-5. PubMed ID: 12811379
[TBL] [Abstract][Full Text] [Related]
39. Effects of Different Mixing Agents on the Stability of Sodium Tetradecyl Sulfate (STS) Foam: An Experimental Study.
Hashimoto K; Uchida B; Horikawa M; Mimura H; Farsad K
Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1952-1957. PubMed ID: 30088060
[TBL] [Abstract][Full Text] [Related]
40. Implication of foam sclerosant inactivation by human whole blood in a laboratory setting.
Dabbs EB; Dos Santos SJ; Mainsiouw LE; Sheikh AA; Gkantiragas A; Shiangoli I; Watkins MR; Nemchand JL; Whiteley MS
Phlebology; 2018 Jun; 33(5):338-343. PubMed ID: 28516808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
